Özlem Tureci (Özlem Türeci, Ӧzlem Türeci)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Coronavirus Disease

Top Venues

Science (New York, N.Y.)

Journal of cancer research and clinical oncology

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Peters, Lena M Kranz, David Eisel, Mustafa Diken, Sebastian Kreiter, Özlem Tureci, Uğur Şahin, Mathias Vormehr
RNA-encoded interleukin-2 with extended bioavailability amplifies RNA vaccine-induced antitumor T-cell immunity. Cancer immunology research (2024)
Florian Lordick, Peter C Thuss-Patience, Michael Bitzer, Daniel Maurus, Uğur Şahin, Özlem Tureci
Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer. Journal of cancer research and clinical oncology (2023)
Jasmin Quandt, Alexander Muik, Nadine Salisch, Bonny Gaby Lui, Sebastian Lutz, Kimberly Krüger, Ann-Kathrin Wallisch, Petra Adams-Quack, Maren Bacher, Andrew Finlayson, Orkun Ozhelvaci, Isabel Vogler, Katharina Grikscheit, Sebastian Hoehl, Udo Goetsch, Sandra Ciesek, Özlem Tureci, Uğur Şahin
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes. Science immunology 7 (75) (2022)
Alexander Muik, Bonny Gaby Lui, Ann-Kathrin Wallisch, Maren Bacher, Julia Mühl, Jonas Reinholz, Orkun Ozhelvaci, Nina Beckmann, Ramón de la Caridad Güimil Garcia, Asaf Poran, Svetlana Shpyro, Andrew Finlayson, Hui Cai, Qi Yang, Kena A Swanson, Özlem Tureci, Uğur Şahin
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera. Science (New York, N.Y.) 375 (6581) (2022)
Christina Krienke, Laura Kolb, Elif Diken, Michael Streuber, Sarah Kirchhoff, Thomas Bukur, Özlem Akilli-Öztürk, Lena M Kranz, Hendrik Berger, Jutta Petschenka, Mustafa Diken, Sebastian Kreiter, Nir Yogev, Esther Von Stebut, Katalin Karikó, Özlem Tureci, Ugur Sahin
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science (New York, N.Y.) 371 (6525) (2021)
Miwa Haranaka, James Baber, Yoichiro Ogama, Masako Yamaji, Masakazu Aizawa, Osamu Kogawara, Ingrid L Scully, Eleni Lagkadinou, Özlem Tureci, Uğur Şahin, Philip R Dormitzer, William C Gruber, Stephen Lockhart
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults. Nature communications 12 (1) (2021)
Alexander Muik, Ann-Kathrin Wallisch, Bianca Sänger, Kena A Swanson, Julia Mühl, Wei Chen, Hui Cai, Daniel Maurus, Ritu Sarkar, Özlem Tureci, Philip R Dormitzer, Uğur Şahin
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. Science (New York, N.Y.) 371 (6534) (2021)
Katharina Reinhard, Benjamin Rengstl, Petra Oehm, Kristina Michel, Arne Billmeier, Nina Hayduk, Oliver Klein, Kathrin Kuna, Yasmina Ouchan, Stefan Wöll, Elmar Christ, David Weber, Martin Suchan, Thomas Bukur, Matthias Birtel, Veronika Jahndel, Karolina Mroz, Kathleen Hobohm, Lena Kranz, Mustafa Diken, Klaus Kühlcke, Özlem Tureci, Uğur Şahin
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors. Science (New York, N.Y.) 367 (6476) (2020)